An open randomized comparative clinical study of Rasnadi Kwath and Shampakadi kwath in the management of Vatrakta with special reference to hyperuricemia.

Conventional treatment for control of hyperuricaemia according to modern science consist of range of

analgesics like opioid analgesics, NSAIDS, Cox inhibitor and xanthine oxidase inhibitor.

However, prolonged utilization of these medications can result in adverse effects like drug dependency,

Gastric irritation, Renal damage.Control of hyperuricaemia is one part of treatment of gout, so making a

comprehensive treatment approach is essential which can be achieved through the Ayurveda.

At this present time Ayurveda gains the ground, as most of ayurvedic medicines are herbal

preparations with minimal or no hazardous side effects. So the thought of exploring a drug which is

having properties to reduce signs and symptoms of Vatarakta and may lower uric acid level as well,

Hence, this clinical research is taken.

Out of many medicines described in texts for the treatment of Vatarakta, Rasnadi kwath has been

selected and planned to use judiciously.

It is explained in the texts, that oral administration of Rasnadi kwath for 21 days gives

relief from pain, stiffness, inflammation, swelling and other symptoms of Vatarakta, Which are seen due

to vitiation of rakta